Heart Health
Heart Disease and Emory Women’s Heart Center
According to the American Heart Association, heart disease is the number one killer of women and is more deadly than all forms of cancer combined. It is also preventable. The Emory Women's Heart Center...
Liver
Real Patients, Real Stories – Hear from an Emory Liver Transplant Patient
Simone Whitehead was an active 30-year-old, running half marathons and chasing around her 2-year-old son. In April 2016, she began to feel ill, and she slowly started getting worse. Tests revealed that her liver...
Psychiatry
Break the Stigma: Let’s Talk About Mental Illness
The words mental illness often bring specific ideas or images to mind. But, the reality is that mental illness affects far more people than you imagine. According to the National Alliance for Mental Illness...
Kidney
Emory Leads Research on FDA-Approved Drug in HIV Positive Patients Receiving Kidney Transplants
Emory Transplant Center will soon begin enrolling patients into a new clinical trial that will test an FDA-approved drug in HIV positive patients receiving a kidney transplant. The research study will evaluate the safety...
Structural Heart
Aortic Stenosis
The aortic valve is tremendously important, controlling blood flow from the heart to the rest of the body. In aortic stenosis, the valve does not open fully, restricting blood flow from the heart. In...
Kidney
Emory Transplant Center Awarded Grant to Reduce Disparities in Access to Transplant
The National Institutes of Minority Health and Health Disparities has awarded $2.6 million over five years to the Emory Transplant Center and six other transplant centers and organizations in the Southeastern Kidney Transplant Coalition....
Liver
Improving Survival Rates for Liver Cancer Patients
Emory is nationally renowned for using a multidisciplinary approach to treat cancer. But many may not know there is a multidisciplinary team right here at the Emory Transplant Center with the mission of improving...
Kidney
Belatacept Provides Better Kidney Survival Rates than Current Standard of Care
A study of kidney transplant recipients has shown for the first time that the drug belatacept (Nulojix), which controls the immune system and prevents graft rejection, has a better record of patient and organ...
